These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35438443)

  • 1. Walking a Fine Germline: Synthesizing Public Opinion and Legal Precedent to Develop Policy Recommendations for Heritable Gene-Editing.
    Benston S
    J Bioeth Inq; 2022 Sep; 19(3):421-431. PubMed ID: 35438443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human genome editing: how to prevent rogue actors.
    Townsend BA
    BMC Med Ethics; 2020 Oct; 21(1):95. PubMed ID: 33023591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaping the CRISPR Gene-Editing Debate: Questions About Enhancement and Germline Modification.
    Johnston J
    Perspect Biol Med; 2020; 63(1):141-154. PubMed ID: 32063593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsible governance of human germline genome editing in China†.
    Peng Y; Lv J; Ding L; Gong X; Zhou Q
    Biol Reprod; 2022 Jul; 107(1):261-268. PubMed ID: 35640230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans.
    Howard HC; van El CG; Forzano F; Radojkovic D; Rial-Sebbag E; de Wert G; Borry P; Cornel MC;
    Eur J Hum Genet; 2018 Jan; 26(1):1-11. PubMed ID: 29192152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioethical issues in genome editing by CRISPR-Cas9 technology.
    Ayanoğlu FB; Elçin AE; Elçin YM
    Turk J Biol; 2020; 44(2):110-120. PubMed ID: 32256147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE.
    De Wert G; Heindryckx B; Pennings G; Clarke A; Eichenlaub-Ritter U; van El CG; Forzano F; Goddijn M; Howard HC; Radojkovic D; Rial-Sebbag E; Dondorp W; Tarlatzis BC; Cornel MC;
    Eur J Hum Genet; 2018 Apr; 26(4):450-470. PubMed ID: 29326429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making sense of heritable human genome editing: Scientific and ethical considerations.
    Greenfield A
    Prog Mol Biol Transl Sci; 2021; 182():1-28. PubMed ID: 34175039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When is it Safe to Edit the Human Germline?
    Baxter J
    Sci Eng Ethics; 2021 Jul; 27(4):43. PubMed ID: 34231047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Australia's Policymakers Can Ethically Approach Human Germline Genome Editing Technology.
    Mangiapane M; Foong P
    J Law Med; 2022 Aug; 29(3):740-759. PubMed ID: 36056664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Acceptability of Gene Therapy and Gene Editing for Human Use: A Systematic Review.
    Delhove J; Osenk I; Prichard I; Donnelley M
    Hum Gene Ther; 2020 Jan; 31(1-2):20-46. PubMed ID: 31802714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline Modification and Policymaking: The Relationship between Mitochondrial Replacement and Gene Editing.
    Cussins J; Lowthorp L
    New Bioeth; 2018 Apr; 24(1):74-94. PubMed ID: 29529982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Editing in Humans: Towards a Global and Inclusive Debate for Responsible Research.
    de Lecuona I; Casado M; Marfany G; Lopez Baroni M; Escarrabill M
    Yale J Biol Med; 2017 Dec; 90(4):673-681. PubMed ID: 29259532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back to Basics: Application of the Principles of Bioethics to Heritable Genome Interventions.
    Getz LJ; Dellaire G
    Sci Eng Ethics; 2020 Oct; 26(5):2735-2748. PubMed ID: 32524426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.
    Isa NM; Zulkifli NA; Man S
    Sci Eng Ethics; 2020 Feb; 26(1):309-323. PubMed ID: 30830592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Germline Genome Editing.
    Ormond KE; Mortlock DP; Scholes DT; Bombard Y; Brody LC; Faucett WA; Garrison NA; Hercher L; Isasi R; Middleton A; Musunuru K; Shriner D; Virani A; Young CE
    Am J Hum Genet; 2017 Aug; 101(2):167-176. PubMed ID: 28777929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Realigning gene editing with clinical research ethics: What the "CRISPR Twins" debacle means for Chinese and international research ethics governance.
    Kleiderman E; Ogbogu U
    Account Res; 2019 May; 26(4):257-264. PubMed ID: 31068009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global bioethics.
    Neuhaus CP
    Hastings Cent Rep; 2017 Nov; 47(6):inside front cover. PubMed ID: 29171055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.